Publications by authors named "W N F 'a Abdul Rashid"

This systematic review evaluates the outcomes of direct-acting antivirals (DAAs) compared to interferon-based therapies in patients with chronic hepatitis C infection. DAAs consistently demonstrate higher sustained virologic response (SVR) rates and better safety profiles across various patient populations, including those with cirrhosis and treatment-experienced individuals. The studies included highlight the superior efficacy of DAAs, with fewer adverse events such as anemia and fatigue, making them more tolerable and suitable for long-term treatment.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how clinical attacks contribute to ongoing disability in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD).
  • A total of 165 patients were analyzed using disability scores recorded after at least six months post-attack, with findings showing a significant increase in disability scores correlating with the number and type of relapses.
  • Results indicated that specific relapse types, particularly the combination of transverse myelitis and optic neuritis, had the most substantial impact on increasing residual disability.
View Article and Find Full Text PDF
Article Synopsis
  • Oral squamous cell carcinoma (OSCC) progresses through various stages, making it hard to distinguish between them using standard histopathology techniques.
  • This study evaluated the expression of the D2-40 marker in different OSCC stages using 30 tissue samples, revealing that D2-40 is strongly expressed in microinvasive and invasive cases compared to high-grade dysplasia.
  • The findings suggest D2-40 could serve as a valuable biomarker for early detection of microinvasion in oral lesions, potentially aiding in more accurate diagnoses.
View Article and Find Full Text PDF

The Association of British Neurologists last published guidelines on disease-modifying treatment (DMT) in multiple sclerosis (MS) in 2015. Since then, additional DMTs have been licensed and approved for prescribing within the National Health Service for relapsing-remitting MS, early primary progressive MS and active secondary progressive MS. This updated guidance provides a consensus-based approach to using DMTs.

View Article and Find Full Text PDF

One of the most prominent symptoms in multiple sclerosis is pathological fatigue, often described by sufferers as one of the most debilitating symptoms, affecting quality of life and employment. However, the mechanisms of both, physical and cognitive fatigue in multiple sclerosis remain elusive. Here, we use behavioural tasks and quantitative MRI to investigate the neural correlates of interoception (the ability to sense internal bodily signals) and metacognition (the ability of the brain to assess its own performance), in modulating cognitive fatigue.

View Article and Find Full Text PDF